Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

The nuclear Ferredoxin reductase and its role in tumor suppression

$4.79M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization University of California At Davis
Country United States
Start Date May 01, 2024
End Date Apr 30, 2029
Duration 1,825 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10882601
Grant Description

Project Summary/Abstract We and others showed that ferredoxin reductase (FDXR), a mitochondrial flavoprotein, is induced by DNA damage in a p53-dependent manner and regulates apoptosis induced by reactive oxygen species. As the only human ferredoxin reductase, FDXR receives two electrons from NADPH and transfers them

one at a time to its cognate substrates ferredoxin 1 (FDX1) and FDX2 and subsequently, plays a role in biogenesis of steroids and iron sulfur cluster proteins. Despite these well-defined biochemical functions, the role of FDXR in tumor suppression is still poorly understood. Interestingly, recent studies

showed that FDXR is the most consistent acute sensor following DNA damage, suggesting that FDXR plays a role in DNA damage response and repair. Indeed, our pilot studies showed that FDXR is also expressed in the nucleus and regulates cell growth and survival potentially via its nuclear substrates (p53, Mdm2, and Mdm4) in response to a stress. These observations prompt us to hypothesize that the

nuclear FDXR has a critical biological function in tumor suppression. To further test this, two specific aims are proposed: (1) To determine how FDXR subcellular localization is regulated; (2) To determine how the nuclear FDXR exerts its biological function.

All Grantees

University of California At Davis

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant